Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis

Checkpoint inhibitors (CPIs) are a new class of drugs that have changed the treatment and prognosis of several malignancies, even in their advanced stages. These drugs have increased patient survival rates. CPIs stimulate the immune system and include cytotoxic T-lymphocyte antigen-4 inhibitors (ipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Jaffar, Katona, Terrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523195/
https://www.ncbi.nlm.nih.gov/pubmed/34692300
http://dx.doi.org/10.7759/cureus.18085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523195/
https://www.ncbi.nlm.nih.gov/pubmed/34692300
http://dx.doi.org/10.7759/cureus.18085

Ejemplares similares